MN1 Gene Meningioma MN1 Deficiency Related NGS Genetic DNA Test
Comprehensive Genetic Testing for Meningioma Risk Assessment
The MN1 Gene Meningioma NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment, specifically targeting mutations in the MN1 gene that have been scientifically linked to increased susceptibility to meningioma development. Meningiomas are among the most common primary brain tumors, affecting the protective membranes surrounding the brain and spinal cord. This advanced genetic test provides crucial information for individuals concerned about their hereditary cancer risk.
What Does the MN1 Gene Meningioma Test Measure?
This sophisticated genetic analysis utilizes Next-Generation Sequencing (NGS) technology to comprehensively examine the MN1 gene for specific mutations and deficiencies. The test detects:
- Point mutations in the MN1 gene sequence
- Gene deletions and duplications affecting MN1 function
- Structural variations impacting MN1 expression
- Epigenetic modifications influencing MN1 activity
- Copy number variations related to MN1 deficiency
The MN1 gene plays a critical role in transcriptional regulation and cellular differentiation processes. When mutations occur in this gene, it can disrupt normal cellular functions and increase the likelihood of meningioma formation through complex molecular pathways.
Who Should Consider This Genetic Test?
This test is particularly recommended for individuals who meet one or more of the following criteria:
- Personal history of meningioma diagnosis at a young age
- Family history of multiple meningioma cases across generations
- Unexplained neurological symptoms including persistent headaches
- Vision changes or hearing loss without clear cause
- Seizures or cognitive changes warranting genetic investigation
- Multiple family members with brain or spinal cord tumors
- Previous radiation exposure to the head or neck region
Clinical Benefits of MN1 Gene Testing
Undergoing MN1 gene testing provides numerous clinical advantages for patients and healthcare providers:
- Early Risk Identification: Detect genetic predisposition before symptoms develop
- Personalized Screening Protocols: Tailor MRI and neurological monitoring schedules
- Family Planning Guidance: Understand inheritance patterns for future generations
- Treatment Planning: Inform surgical and therapeutic approaches if needed
- Psychological Relief: Reduce uncertainty through definitive genetic information
- Preventive Strategies: Implement lifestyle and environmental modifications
Understanding Your Test Results
Your MN1 gene test results will fall into one of several categories, each with specific implications:
- Negative Result: No pathogenic MN1 mutations detected – indicates average population risk for meningioma development
- Positive Result: Pathogenic mutation identified – suggests increased meningioma risk requiring enhanced surveillance
- Variant of Uncertain Significance: Genetic change detected with unknown clinical impact – may require additional family studies
- Benign Polymorphism: Common genetic variation not associated with disease risk
All results are accompanied by comprehensive genetic counseling to ensure proper interpretation and appropriate next steps. Our certified genetic counselors will explain your results in detail and help develop a personalized management plan.
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
Pre-Test Requirements
Before scheduling your MN1 gene test, please ensure you have:
- Complete clinical history documentation
- Genetic counseling session scheduled
- Family pedigree chart prepared showing affected relatives
- Relevant medical records available for review
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible genetic testing services nationwide.
Take Control of Your Genetic Health Today
Don’t let uncertainty about your genetic risk for meningioma affect your peace of mind. Our MN1 Gene Meningioma NGS Genetic DNA Test provides the clarity and information you need to make informed healthcare decisions. With advanced NGS technology, comprehensive genetic counseling, and affordable pricing at only $500 USD, there’s never been a better time to understand your genetic profile.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your appointment or book your test online. Our genetic specialists are ready to answer your questions and guide you through the testing process.
